![Sheila Gujrathi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheila Gujrathi
Chairman at
PROCESSA PHARMACEUTICALS, INC.
Net worth: 4 M $ as of 2026-09-29
Profile
Sheila Gujrathi is a businessperson who founded Gossamer Bio, Inc. and who has been the head of 5 different companies. Dr. Gujrathi occupies the position of Chairman at Turning Point Therapeutics, Inc., Chairman of ADARx Pharmaceuticals, Inc., Chief Executive Officer of GB001, Inc. and Chief Executive Officer of GB006, Inc. Sheila Gujrathi is also on the board of Janux Therapeutics, Inc. In the past she was President, Chief Executive Officer & Director at Gossamer Bio, Inc., Vice President-Global Clinical Development Group at Bristol Myers Squibb Co. and Chief Medical Officer at Receptos LLC (a subsidiary of Bristol Myers Squibb Co.) and Franchise Team Leader at Genentech, Inc. She received a doctorate and an undergraduate degree from Northwestern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-14 | 112,639 ( 0.19% ) | 2 M $ | 2026-09-29 | |
| 2026-08-06 | 90,160 ( 0.28% ) | 2 M $ | 2026-09-29 |
Sheila Gujrathi active positions
| Companies | Position | Start |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Director/Board Member | 2021-03-17 |
| PROCESSA PHARMACEUTICALS, INC. | Chairman | 2026-10-27 |
| BLOSSOMHILL THERAPEUTICS, INC. | Director/Board Member | 2026-04-30 |
| BOLT BIOTHERAPEUTICS, INC. | Director/Board Member | 2026-10-22 |
Generian Pharmaceuticals, Inc.
 Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Chairman | 2023-04-30 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Consultant / Advisor | - |
GB006, Inc.
 GB006, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Chief Executive Officer | - |
Former positions of Sheila Gujrathi
| Companies | Position | End |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Chairman | 2026-03-03 |
| ADARX PHARMACEUTICALS, INC. | Chairman | 2024-12-31 |
| ░░░░░░░ ░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Education of Sheila Gujrathi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
GB001, Inc.
 GB001, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
GB006, Inc.
GB006, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Generian Pharmaceuticals, Inc.
Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Health Technology |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops siRNA therapeutics to treat diseases | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Sheila Gujrathi
